Pfizer stock down 6% after Q3 earnings despite raised guidance
FROM THE WIRE · FINANCE.YAHOO.COM
Pfizer's PFE shares have declined 5.9% since the company reported third-quarter results on Nov. 3. Pfizer beat estimates for both earnings and revenues in the third quarter. Adjusted earnings of 87 cents per share and revenues of $16.58 billion were both flat year over year.…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralA large pharma stock fell despite better-than-expected results and raised guidance.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Pfizer beat estimates for earnings and revenues in the third quarter.
- 02Adjusted earnings were 87 cents per share and revenues $16.58 billion.
- 03The company raised 2026 revenue and earnings guidance, yet shares fell 5.9%.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets